Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Depression screening by nurses in people on long-term kidney dialysis

Official title: Evaluation of Depression Screening Methods Administered by Registered Nurses in Chronic Hemodialysis Patients

Run by Centre Hospitalier Annecy Genevois · NCT07651436 · Data updated 2026-11-12

This study tests how well nurses can screen for depressive symptoms in people receiving chronic hemodialysis to see if it helps identify those in need of support.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment450 (estimated)
SponsorCentre Hospitalier Annecy Genevois
Academic / other
Locations2 sites (Annecy and 1 other locations)
StatusRecruiting
StartedJune 26, 2026
Main results expectedJune 2028
Study endsOctober 2028
Registry record updatedOctober 20, 2026
Trial IDNCT07651436 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults on conventional hemodialysis for at least 3 months, fluent in French, and able to consent.

Probably not a fit

Patients with dementia, language barriers preventing self-assessment, or those not at risk for depression may see no direct benefit from this screening approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study investigates the performance of nurse-administered, hetero-assessed depression screening methods in adults undergoing conventional hemodialysis for at least three months. The goal is to compare different modalities used by nurses to detect depressive symptoms, with the aim of improving early identification and management. The study is conducted in French-speaking centers and involves patients who are on a three-times-weekly dialysis schedule and able to provide consent. Exclusion criteria include dementia, pregnancy, language barriers hindering self-assessment, and current participation in another interventional trial. The overall focus is on whether nurse-led screening can better capture depressive symptoms and potentially influence patient outcomes in this population.

Why it matters

Potential benefit: If successful, the approach could improve early detection of depression among dialysis patients and prompt timely support and treatment.

How similar studies have gone: Previous studies have explored nurse-led or hetero-assessed screenings in chronic disease care, showing potential benefits in detection, though results vary by setting and method.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient informed about the nature, process, and objectives of the study and having signed a free and informed consent to participate,
* Patient treated with conventional hemodialysis for at least 3 months and currently undergoing dialysis 3 times a week,
* Patient covered by the french national social welfare

Exclusion Criteria:

* Patient suffering from dementia
* Pregnant or breastfeeding patient
* Patient unable to understand the French language both orally and in writing, - making self-assessment impossible
* Patient currently participating in another interventional research protocol or in an exclusion period from such research
* Patient who has already been included in this study
* Patient under guardianship, curatorship, or placed under judicial protection.

Where it's running

  • Centre Hospitalier Annecy Genevois
    Annecy, France
    Recruiting
  • Centre Hospitalier Métropole Savoie
    Chambéry, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.